MoneyWorks4Me

Bliss GVS Pharma - Quaterly Results

01 Aug 2023 Evaluate
Net sales declined -26.00%  to  Rs. 1089.92 million from Rs. 1472.80 millions.Profit after Tax for the quarter ended June 2023 saw a decline of -69.58% from Rs. 246.44 millions to Rs. 74.96  millions.A decline of 175.78 millions was observed in the OP in the quarter ended June 2023 from 377.81 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 1089.92 1472.80 -26.00 1089.92 1472.80 -26.00 5983.40 6363.57 -5.97
Other Income 65.27 186.34 -64.97 65.27 186.34 -64.97 507.66 326.28 55.59
PBIDT 175.78 377.81 -53.47 175.78 377.81 -53.47 1409.21 1418.26 -0.64
Interest 13.09 20.42 -35.90 13.09 20.42 -35.90 100.57 43.24 132.59
PBDT 162.69 357.39 -54.48 162.69 357.39 -54.48 1308.64 1402.47 -6.69
Depreciation 53.64 36.74 46.00 53.64 36.74 46.00 151.73 138.47 9.58
PBT 109.05 320.65 -65.99 109.05 320.65 -65.99 1156.91 1264.00 -8.47
TAX 34.09 74.21 -54.06 34.09 74.21 -54.06 302.14 337.36 -10.44
Deferred Tax 7.00 -12.25 -157.14 7.00 -12.25 -157.14 -42.10 7.68 -648.18
PAT 74.96 246.44 -69.58 74.96 246.44 -69.58 854.77 926.64 -7.76
Equity 104.22 103.81 0.39 104.22 103.81 0.39 104.15 103.68 0.45
PBIDTM(%) 16.13 25.65 -37.13 16.13 25.65 -37.13 23.55 22.29 5.68
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..